Yoshie Imai and Tomoka Sakamoto : ヘルスプロモーション, Nankodo, Tokyo, May 2024.
Academic Paper (Judged Full Paper):
1.
Yoshie Imai, MIYAMOTO Yoko, YOSHIDA Yukiko, Yuta Inoue, IMAI Hironori, YAMADA Kazuyo, Tomoka Sakamoto and Hiroyuki Morino : ASCERTAINING THE VIEWS OF HEREDITARY CANCER SYNDROME PATIENTS RECEIVING GENETIC COUNSELING AND THEIR FAMILIES REGARDING GENETIC TESTING, Journal of Comprehensive Nursing Research and Care, 10, 2, 219, 2025.
(Summary)
This study investigates how genetic information could be shared by ascertaining the views of patients receiving genetic counseling (GC) for suspected hereditary cancer and their families regarding genetic testing. We conducted a questionnaire survey of hereditary cancer syndrome patients receiving GC for the first time after the disclosure of genetic testing results as well as their spouses and at-risk relatives. A total of 81 people responded: 50 patients who received GC during the study period, 18 spouses, and 13 at-risk relatives. We found significant differences in responses to the questions ``1-1: Are you interested in genetic testing?'' (p < .003), ``1-5: Do you think genetic testing has drawbacks?'' (p < .007), ``1-9: Is it necessary to undergo genetic testing?'' (p < .001), and ``Q2: How did you think about communicating genetic information to family or relatives?'' (p < .003) between patients and spouses. There was a significant difference among all groups for ``1-4: Do you want to clarify whether you have a genetic variant or not?'' (p < .001). We also found a significant difference in the question ``1-11: Is genetic testing too expensive?'' between patients on one side and spouses and at-risk relatives on the other (p < .001). We surveyed the views on genetic testing of hereditary cancer syndrome patients and their families and found that both groups recognize the importance of learning the test results. However, the two groups did not agree on ``Do you want to clarify whether you have a genetic variant or not?'' through genetic testing.
(Keyword)
genetic counseling / hereditary cancer syndrome patients / genetic testing
Yoshie Imai, Yuka Mori, 御手洗 幸子, 入澤 裕子, 大川 恵, 日下 咲, 下川 亜矢, 納富 理絵, 松本 仁美, Akiko Abe, Kanako Yoshida, 村上 好恵, 武田 祐子, 川崎 優子 and Tomoka Sakamoto : ) International Trends in Decision-making Regarding Risk-reducing Salpingo-oophorectomy for Hereditary Breast and Ovarian Cancer Syndrome, Shikoku Acta Medica, 79, 5,6, 245-252, 2024.
(Summary)
<p>Hereditary breast and ovarian cancer syndrome (HBOC) has been reported to account for about 10-15% of all ovarian cancers, and risk-reducing salpingo-oophorectomy (RRSO) is regarded as the only preventive measure against the risk of such cancers. It is important for patients with BRCA 1/2 pathogenic variants to undergo RRSO after childbearing, between the ages of 35 to 45, but a multifaceted perspective is needed when considering this procedure, as it may cause physical and psychological problems. This paper discusses factors that influence decision-making regarding RRSO from three perspectives : demographics, medical history, and psychosociology, with reference to previous studies. Accurate insight into the background that led to the decision to undergo RRSO is crucial for support. Above all, it is essential to utilize such insight in healthcare as vital information to prevent death from breast or ovarian cancer among HBOC patients.</p>
(Keyword)
decision making / Regarding Risk-reducing Salpingo-oophorectomy / Hereditary Breast and Ovarian Cancer Syndrome
Yuka Mori, Yoshie Imai, Takae Bando, Aki Takahashi, Yuta Inoue and Tomoka Sakamoto : がん自壊創を有する患者に関わる看護師の困難感の要素, Journal of Japanese Society of Cancer Nursing, 37, 147-155, 2023.
村上 好恵, Yoshie Imai, 武田 祐子, 川崎 優子, 浅海 くるみ, Yuka Mori, Yuta Inoue and Tomoka Sakamoto : Current Status of Oncology Certified Nurse Specialist Involvement in Cancer Genome Medicine, Shikoku Acta Medica, 79, 3 4, 165-172, 2023.
(Summary)
The purpose of this study was to clarify the current status of oncology certified nurse specialist(OCNS) involvement in cancer genome medicine. A survey of 235 OCNSs who consented to participate in the study revealed that those involved in cancer genome medicine had a better understanding of hereditary tumors. Through descriptive content analysis, 8 learning needs were identified in relation to cancer genome medicine. Among these needs,[ basic nowledge of hereditary tumors and cancer genome medicine], [regular acquisition of up-to-date information on genetic medicine], and[ genetic counseling in actual clinical settings] revealed no differences between OCNSs involved and not involved in genetic medicine. On the other hand,[ role of an OCNS in genetic medicine], [nursing care for patients and families with hereditary diseases], [systems and collaboration to incorporate genetic medicine into rganizations], [information on genetic medicine for facilities other than urban/designated hospitals], and[ programmed learning as a systematic approach to genetic medicine provided by academic societies] differed between the groups in terms of descriptive contents.
(Keyword)
Oncology Certified Nurse Specialist / Cancer Genome Medicine / involvement
Yoshie Imai, Yoshie Murakami, Yuko Takeda, Yuko Kawasaki, Megumi Kishino, Yuka Mori, Megumi Kageyama, Tomoka Sakamoto, Takae Bando and Kazuya Kondo : Process of parenting a child with retinoblastoma while guiding him or her toward disease acceptance, Shikoku Acta Medica, 79, 1.2, 91-102, 2023.
(Summary)
<p>Background :</p><p>Retinoblastoma (RB) occurs at a very young age. Since the disease is diagnosed at an early age, the family is responsible for the care of the child s disease acceptance.</p><p>Objective : This study aims to explore the parenting process of children with RB toward disease acceptance.</p><p>Methods : Parents of eleven children with RB living in Japan were interviewed, and the data were analyzed using the Modified Grounded Theory Approach of Kinoshita (M-GTA).</p><p>Results : There were twenty-one concepts representing the process of parenting a child with RB while guiding him or her toward disease acceptance, and nineteen of them were classified into</p><p>ten categories based on semantic similarities. The two other concepts showed similar interpretability to categories. These categories and concepts were summarized into two core categories :</p><p>``Helping the child develop a positive mindset to define the disease as a part of him/herself'' and</p><p>``Paving the way in advance for the child to live comfortably when his or her living space expands''.</p><p>Conclusions : In a cyclical framework of parenting, consisting of two core categories described</p><p>in Results, the parents coordinated these two approaches while maintaining balance by ``Avoiding saying anything that does not need to be said'' and established their process of parenting a child</p><p>with RB while guiding him or her toward disease acceptance, according to their household situation. The results suggest the necessity of recognizing that in childhood-onset cancers, such as RB,</p><p>and diseases involving genetic issues, problems tend to occur not only during the treatment period but also at the time of life events and providing support from a comprehensive perspective.</p>
(Keyword)
experience / Family nursing / genetics / Parenting / Retinoblastoma
杉本 沙紀, Yoshie Imai, 上田 伊佐子, Kazuya Kondo, 高開 登茂子, 長谷 奈生己, Takae Bando, Aki Takahashi, Yuta Inoue, Yuka Mori, Tomoka Sakamoto and 蔭山 恵美 : Self-evaluation of Nursing Practice for Elderly Cancer Patients with Dementia Receiving Treatment in Acute Care Hospitals and Factors Influencing It, Shikoku Acta Medica, 79, 1,2, 79-90, 2023.
(Summary)
The purpose of this study was to clarify the current status of nursing practice for elderly cancer patients with dementia receiving treatment in acute care hospitals and related factors An anonymous self-administered questionnaire survey was conducted from May to July 2021 involving 400 people with experience of providing nursing care for elderly cancer patients with dementia Factor analysis identified <considering situations where patients have difficulty in managing their own safety> and <making arrangements to help patients maintain ordinariness> as factors of self-evaluation of nursing practice for elderly cancer patients with dementia receiving treatment in acute care hospitals Such evaluation was influenced by <years of nursing experience> <years of providing nursing care for elderly cancer patients with dementia> <participation in study groups/training seminars on dementia> <knowledge of dementia> <status of nursing practice for dementia> and <ethical behavior>
(Keyword)
elderly cancer patients with dementia / acute-phase hospitals / nursing care
岡本 恵, Yoshie Imai, Takae Bando, Aki Takahashi, Yuta Inoue and Tomoka Sakamoto : Dealing with Reality as a Cancer Patient when Continuing Current Cancer Treatment without Possibility of New Treatment as Determined by Cancer Panel Examination, Journal of Japanese Society of Cancer Nursing, 37, 1, 52-59, 2023.
(Summary)
<p>To clarify cancer patients' experience of dealing with reality after being notified of their cancer genomic profiling results which did not lead to new treatments, a qualitative descriptive study was performed. Semi-structured interviews were conducted with 10 cancer patients who had received cancer genomic profiling and had been notified that their results did not lead to new treatments. Their experience of dealing with reality after being notified of such results was summarized into the following 5 categories: accepting the results in a constructive manner by deeming that genetic information paves the way for future treatments, finding the situation acceptable because of one's stable condition even without new treatments, controlling one's emotional ups and downs by not clinging to something as a ray of hope, believing in oneself for having survived until now, and having people understand oneself as someone with no way out. Cancer patients' experience of dealing with reality after being notified of their cancer genomic profiling results which did not lead to new treatments were characterized by ``having fewer options, but feeling that one can live a little more'' and ``using one's strength of fully understanding one's present self for emotional control''. The results suggest that these patients need to find circumstances that allow them to think about their future even in a severe situation, and medical staff need to promote their understanding of the characteristics of genomic profiling, understand their emotions, and continuously support them to help them deal with reality.</p>
(Keyword)
cancer genomic profiling / cancer patients / dealing with reality
Yoshie Imai, Akiko Abe, 村上 好恵, 武田 祐子, 川崎 優子, Takae Bando, Aki Takahashi, Yuta Inoue, Tomoka Sakamoto and Kanako Yoshida : Emotions of patients with hereditary breast and ovarian cancer syndrome after risk reducing salpingo-oophorectomy, Journal of Hereditary Tumors, 22, 3, 68-74, 2022.
(Keyword)
breast cancer patients / hereditary breast and ovarian cancer syndrome(HBOC) / risk reducing salpingo-oophorectomy (RRSO)
Yoshie Imai, Chiemi Onishi, Yasue Kawabata, Mika Machida, Akiko Tokunaga, Aoi Enomoto, Hiromi Arahori, Isako Ueda, Takae Bando, Yuta Inoue, Aki Takahashi and Tomoka Sakamoto : Development of a Cancer Treatment Acceptance Scale, Journal of Japan Academy of Nursing Science, 42, 0, 281-290, 2022.
(Summary)
Objective: This study aims to develop a scale for measuring cancer treatment acceptance and to examine its reliability and validity, which will help patient accept and complete cancer treatment. Methods: A questionnaire survey was conducted, involving 294 cancer patients receiving treatment. The reliability and validity of the developed cancer treatment acceptance scale were confirmed by examining evidence in content, from substantive, structural, generalizability, and external aspects. Results: Responses were obtained from 235 patients (response rate: 79.9%), and 210, who returned valid responses, were analyzed. To verify the reliability and validity of the scale, item analysis was performed. Through factor analysis for 28 items finally adopted, 2 factors, [the value of treatment] and [a positive feeling about treatment], and 18 items were identified. The goodness of fit of this model was represented by GFI = 0.901, AGFI = 0.853, CFI = 0.919, and RMSE = 0.049. The correlation coefficient with Decisional Conflict Scale was r = 0.589 to 0.667. Cronbach's alpha for each factor ranged from 0.915 to 0.945. Conclusions: We developed a scale consisting of 2 factors with 18 items to measure cancer treatment acceptance and confirmed its reliability and validity.
(Keyword)
acceptance / cancer treatment / development of a scale
The purpose of this study was to characterize periods of hospital-to-home care transition for elderly cancer patients by extracting definitions of such periods and their characteristics as situations from the literature, and to discuss effective nursing support toward hospital-to-home care transition. Relevant research papers published within the period between 2010 and 2020 were searched for using Ichushi Web and PubMed. Descriptions related to periods of transition, characteristics of situations, and hindering/promoting factors were extracted without any changes and categorized based on descriptive content similarities. In these papers, a period of hospital-to-home care transition was described as 1 week to 1 year after discharge. As a situation, it was characterized as ``a time when the patient rebuilds his/her life'', and therefore, ``a time of instability''. Factors hindering and promoting hospital-to-home care transition were represented by6categories, which suggested the following commonalities between them : [ physical management],[patients'/families' intentions],[home care systems],[other family members' commitments to home care], [collaboration systems], and[nurses' home care experience].
(Keyword)
Elderly Cancer Patients / Hospital-to-home Care Transition / Literature Review